The demand for Immunosuppressants in Paraguay is on the rise, and there are several reasons for this trend.
Customer preferences: Patients suffering from autoimmune disorders, organ transplants, and other conditions that require immunosuppressants are the primary customers in this market. The preference for these drugs is increasing due to their effectiveness in managing these chronic conditions.
Trends in the market: One of the significant trends in the Paraguayan market is the increasing availability of generic immunosuppressants. These drugs are more affordable than their branded counterparts, making them accessible to a larger population. Moreover, the government is taking steps to ensure that these drugs meet the same safety and efficacy standards as branded drugs, further boosting their popularity.Another trend is the growing awareness of the benefits of early diagnosis and treatment of autoimmune disorders. This has led to an increase in the number of patients seeking medical attention, resulting in higher demand for immunosuppressants.
Local special circumstances: Paraguay has a high prevalence of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. This has contributed to the high demand for immunosuppressants in the country. Additionally, the country has a shortage of specialists in these fields, resulting in longer waiting times for patients seeking treatment. This has led to a higher demand for immunosuppressants as a stop-gap measure to manage symptoms until patients can receive specialized care.
Underlying macroeconomic factors: The Paraguayan economy has been growing steadily over the past decade, with a focus on developing the healthcare sector. This has resulted in increased investment in medical research and infrastructure, making it easier for patients to access healthcare services. Additionally, the government has introduced policies to improve access to healthcare for low-income families, further boosting demand for immunosuppressants.In conclusion, the demand for immunosuppressants in Paraguay is growing due to several factors, including the increasing availability of generic drugs, growing awareness of the benefits of early diagnosis and treatment, high prevalence of autoimmune disorders, and government initiatives to improve access to healthcare.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
